Table 1.
Clinical features of two clusters.
| Cluster 1 | Cluster 2 | P value | |
|---|---|---|---|
| Number | 217 | 218 | |
| Age (median [IQR]) | 66.00 [56.00, 75.00] | 71.00 [61.00, 80.00] | <0.001 |
| Gender (%) | 0.312 | ||
| female | 97 (44.7) | 109 (50.0) | |
| male | 120 (55.3) | 109 (50.0) | |
| T stage (%) | 0.42 | ||
| T1 | 5 (2.3) | 5 (2.3) | |
| T2 | 40 (18.4) | 34 (15.6) | |
| T3 | 151 (69.6) | 147 (67.4) | |
| T4 | 21 (9.7) | 32 (14.7) | |
| N stage (%) | 0.029 | ||
| N0 | 114 (52.5) | 141 (64.7) | |
| N1 | 60 (27.6) | 41 (18.8) | |
| N2 | 43 (19.8) | 36 (16.5) | |
| M stage (%) | 0.098 | ||
| M0 | 157 (80.5) | 170 (87.2) | |
| M1 | 38 (19.5) | 25 (12.8) | |
| Pathological stage (%) | 0.033 | ||
| Stage I | 36 (16.6) | 38 (17.4) | |
| Stage II | 73 (33.6) | 100 (45.9) | |
| Stage III | 70 (32.3) | 55 (25.2) | |
| Stage IV | 38 (17.5) | 25 (11.5) |